BioCentury
ARTICLE | Company News

Phanos Technologies Inc., Zynaxis deal

February 10, 1997 8:00 AM UTC

ZNXS will sell its Zyn-Linker drug delivery technology to Phanos for $725,000. The sale does not affect ZNXS's December 1996 plan to merge with Vaxcel Inc. (Atlanta, Ga.) to create a publicly held va...